Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Aqueous Humor Cytokines and Long-Term Response to Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema.

Felfeli T, Juncal VR, Hillier RJ, Mak MYK, Wong DT, Berger AR, Kohly RP, Kertes PJ, Eng KT, Boyd SR, Altomare F, Giavedoni LR, Muni RH.

Am J Ophthalmol. 2019 Oct;206:176-183. doi: 10.1016/j.ajo.2019.04.002. Epub 2019 Apr 6.

PMID:
30959004
2.

Same-Day Bilateral Intravitreal Anti-Vascular Endothelial Growth Factor Injections: Experience of a Large Canadian Retina Center.

Juncal VR, Francisconi CLM, Altomare F, Chow DR, Giavedoni LR, Muni RH, Berger AR, Wong DT.

Ophthalmologica. 2019;242(1):1-7. doi: 10.1159/000499115. Epub 2019 Mar 29. Review.

3.

The Pneumatic Retinopexy versus Vitrectomy for the Management of Primary Rhegmatogenous Retinal Detachment Outcomes Randomized Trial (PIVOT).

Hillier RJ, Felfeli T, Berger AR, Wong DT, Altomare F, Dai D, Giavedoni LR, Kertes PJ, Kohly RP, Muni RH.

Ophthalmology. 2019 Apr;126(4):531-539. doi: 10.1016/j.ophtha.2018.11.014. Epub 2018 Nov 22.

PMID:
30468761
4.

Ocriplasmin versus vitrectomy for the treatment of macular holes.

Juncal VR, Chow DR, Vilà N, Kapusta MA, Williams RG, Kherani A, Berger AR.

Can J Ophthalmol. 2018 Oct;53(5):441-446. doi: 10.1016/j.jcjo.2018.01.017. Epub 2018 Mar 21.

PMID:
30340707
5.

Surgical management of submacular hemorrhage: experience at an academic Canadian centre.

Juncal VR, Hanout M, Altomare F, Chow DR, Giavedoni LR, Muni RH, Wong DT, Berger AR.

Can J Ophthalmol. 2018 Aug;53(4):408-414. doi: 10.1016/j.jcjo.2017.10.010. Epub 2017 Dec 23.

PMID:
30119797
6.

Multidisciplinary amyotrophic lateral sclerosis telemedicine care: The store and forward method.

Pulley MT, Brittain R, Hodges W, Frazier C, Miller L, Matyjasik-Liggett M, Maurer S, Peters M, Solomon K, Berger AR.

Muscle Nerve. 2019 Jan;59(1):34-39. doi: 10.1002/mus.26170. Epub 2018 Aug 1.

PMID:
29802746
7.

Aqueous Humor Cytokine Levels and Anatomic Response to Intravitreal Ranibizumab in Diabetic Macular Edema.

Hillier RJ, Ojaimi E, Wong DT, Mak MYK, Berger AR, Kohly RP, Kertes PJ, Forooghian F, Boyd SR, Eng K, Altomare F, Giavedoni LR, Nisenbaum R, Muni RH.

JAMA Ophthalmol. 2018 Apr 1;136(4):382-388. doi: 10.1001/jamaophthalmol.2018.0179.

8.

Age-related macular degeneration: is polypoidal choroidal vasculopathy recognized and treated?

Chen YN, Devenyi RG, Brent MH, Kertes PJ, Eng KT, Schwartz CE, Kohly RP, Chow DR, Wong DT, Berger AR, Altomare F, Giavedoni LR, Muni RH, Soon A, Yoo P, Lam WC.

Can J Ophthalmol. 2017 Oct;52(5):475-479. doi: 10.1016/j.jcjo.2017.02.014. Epub 2017 May 8.

PMID:
28985807
9.

Use of Evicel Fibrin Sealant in Optic Disc Pit-Associated Macular Detachment.

de Oliveira PRC, Berger AR, Chow DR.

Ophthalmic Surg Lasers Imaging Retina. 2017 Apr 1;48(4):358-363. doi: 10.3928/23258160-20170329-13.

PMID:
28419404
10.

Optical coherence tomography angiography in chorioretinal disorders.

De Oliveira PR, Berger AR, Chow DR.

Can J Ophthalmol. 2017 Feb;52(1):125-136. doi: 10.1016/j.jcjo.2016.07.015. Epub 2016 Nov 28. Review.

PMID:
28237138
11.

Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study.

Holz FG, Tadayoni R, Beatty S, Berger AR, Cereda MG, Hykin P, Staurenghi G, Wittrup-Jensen K, Nilsson J, Kim K, Sivaprasad S.

Eye (Lond). 2017 Jan;31(1):166. doi: 10.1038/eye.2016.276. No abstract available.

12.

PROPORTION OF PATIENTS WITH MACULAR HOLE SURGERY WHO WOULD HAVE BEEN FAVORABLE OCRIPLASMIN CANDIDATES: A Retrospective Analysis.

Chaudhary K, Mak MY, Gizicki R, Muni RH, Wong DT, Altomare F, Berger AR.

Retina. 2017 Jan;37(1):76-79. doi: 10.1097/IAE.0000000000001143.

PMID:
28005718
13.

Vitreoretinal instruments: vitrectomy cutters, endoillumination and wide-angle viewing systems.

de Oliveira PR, Berger AR, Chow DR.

Int J Retina Vitreous. 2016 Dec 5;2:28. eCollection 2016. Review.

14.

Identifying Predictors of Anti-VEGF Treatment Response in Patients with Neovascular Age-Related Macular Degeneration through Discriminant and Principal Component Analysis.

Holz FG, Tadayoni R, Beatty S, Berger AR, Cereda MG, Hykin P, Hoyng CB, Wittrup-Jensen K, Altemark A, Nilsson J, Kim K, Sivaprasad S.

Ophthalmic Res. 2017;58(1):49-55. doi: 10.1159/000449001. Epub 2016 Nov 11.

PMID:
27832661
15.

AQUEOUS HUMOR CYTOKINE LEVELS AS BIOMARKERS OF DISEASE SEVERITY IN DIABETIC MACULAR EDEMA.

Hillier RJ, Ojaimi E, Wong DT, Mak MY, Berger AR, Kohly RP, Kertes PJ, Forooghian F, Boyd SR, Eng K, Altomare F, Giavedoni LR, Nisenbaum R, Muni RH.

Retina. 2017 Apr;37(4):761-769. doi: 10.1097/IAE.0000000000001210.

PMID:
27471825
16.

Low-glycaemic index diet to improve glycaemic control and cardiovascular disease in type 2 diabetes: design and methods for a randomised, controlled, clinical trial.

Chiavaroli L, Mirrahimi A, Ireland C, Mitchell S, Sahye-Pudaruth S, Coveney J, Olowoyeye O, Maraj T, Patel D, de Souza RJ, Augustin LS, Bashyam B, Blanco Mejia S, Nishi SK, Leiter LA, Josse RG, McKeown-Eyssen G, Moody AR, Berger AR, Kendall CW, Sievenpiper JL, Jenkins DJ.

BMJ Open. 2016 Jul 7;6(7):e012220. doi: 10.1136/bmjopen-2016-012220.

17.

Long-term Follow-up of a Case of Gold Shunt Surgery for Refractory Silicone Oil-induced Glaucoma.

Le R, Berger AR, Gupta N.

J Glaucoma. 2016 Aug;25(8):e734-7. doi: 10.1097/IJG.0000000000000450.

18.

Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study.

Holz FG, Tadayoni R, Beatty S, Berger AR, Cereda MG, Hykin P, Staurenghi G, Wittrup-Jensen K, Nilsson J, Kim K, Sivaprasad S.

Eye (Lond). 2016 Aug;30(8):1063-71. doi: 10.1038/eye.2016.90. Epub 2016 May 20. Erratum in: Eye (Lond). 2017 Jan;31(1):166.

19.

Real-world utilization of ranibizumab in wet age-related macular degeneration patients from Canada.

Devenyi R, Maberley D, Sheidow TG, Tourville E, Brunck L, Berger AR.

Can J Ophthalmol. 2016 Apr;51(2):55-7. doi: 10.1016/j.jcjo.2015.11.008. No abstract available.

PMID:
27085258
20.

Using Patient-Level Data to Develop Meaningful Cross-Trial Comparisons of Visual Impairment in Individuals with Diabetic Macular Edema.

Sivaprasad S, Regnier SA, Fajnkuchen F, Wright J, Berger AR, Mitchell P, Larsen M.

Adv Ther. 2016 Apr;33(4):597-609. doi: 10.1007/s12325-016-0310-0. Epub 2016 Mar 7.

21.

Optimal Treatment of Retinal Vein Occlusion: Canadian Expert Consensus.

Berger AR, Cruess AF, Altomare F, Chaudhary V, Colleaux K, Greve M, Kherani A, Mandelcorn ED, Parsons H, Rhéaume MA, Tourville E.

Ophthalmologica. 2015;234(1):6-25. doi: 10.1159/000381357. Epub 2015 Jun 12. Review.

PMID:
26088287
22.

Subconjunctival lidocaine before laser treatment: a randomized trial.

Tesha PE, Giavedoni LR, Berger AR, Altomare F, Chow DR, Navajas EV, Yoganathan P, Wong DT, Principe A.

Ophthalmology. 2010 Sep;117(9):1810-4. doi: 10.1016/j.ophtha.2010.01.036. Epub 2010 Jun 8.

PMID:
20570360
23.

Endophthalmitis post complicated cataract surgery associated with Klebsiella pneumoniae.

Becker HM, Yoganathan P, Berger AR.

Ann Ophthalmol (Skokie). 2009 Fall-Winter;41(3-4):189-90.

PMID:
20214054
24.

Inadvertent subretinal triamcinolone injection in a case of recurrent scleritis.

Herschorn AB, Yoganathan P, Margolin EA, Berger AR.

Can J Ophthalmol. 2009 Aug;44(4):e33-4. doi: 10.3129/i09-076. No abstract available.

PMID:
19610249
25.

Diagnosis and Treatment of Chronic Immune-mediated Neuropathies.

Latov N, Gorson KC, Brannagan TH 3rd, Freeman RL, Apostolski S, Berger AR, Bradley WG, Briani C, Bril V, Busis NA, Cros DP, Dalakas MC, Donofrio PD, Dyck PJ, England JD, Fisher MA, Herrmann DN, Menkes DL, Sahenk Z, Sander HW, Triggs WJ, Vallat JM.

J Clin Neuromuscul Dis. 2006 Mar;7(3):141-57.

PMID:
19078800
26.

Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy.

Berger AR, Bradley WG, Brannagan TH, Busis NA, Cros DP, Dalakas MC, Danon MJ, Donofrio P, Engel WK, England JD, Feldman EL, Freeman RL, Kinsella LJ, Lacomis D, Latov N, Menkes DL, Sander HW, Thomas FP, Triggs WJ, Windebank AJ, Wolfe GI; Neuropathy Association, Medical Advisory Committee.

J Peripher Nerv Syst. 2003 Dec;8(4):282-4. No abstract available.

PMID:
14641652
27.

Vasoproliferative tumours of the retina.

Jain K, Berger AR, Yucil YH, McGowan HD.

Eye (Lond). 2003 Apr;17(3):364-8.

PMID:
12724700
28.

Electrophysiologic correlates of weakness in L5/S1 radiculopathy.

Scelsa SN, Berger AR, Herskovitz S.

Electromyogr Clin Neurophysiol. 2001 Apr-May;41(3):145-51.

PMID:
11402506
29.

An assessment of intraocular pressure rise in patients with gas-filled eyes during simulated air flight.

Mills MD, Devenyi RG, Lam WC, Berger AR, Beijer CD, Lam SR.

Ophthalmology. 2001 Jan;108(1):40-4.

PMID:
11150262
30.

Pneumatic displacement of submacular hemorrhage.

Averbukh E, Devenyi RG, Lam WC, Berger AR.

Ophthalmology. 2000 Dec;107(12):2118-9. No abstract available.

PMID:
11097563
31.

Lipemia retinalis in acquired immunodeficiency syndrome treated with protease inhibitors.

Eng KT, Liu ES, Silverman MS, Berger AR.

Arch Ophthalmol. 2000 Mar;118(3):425-6. No abstract available.

PMID:
10721972
32.

Visual outcome following penetrating globe injuries with retained intraocular foreign bodies.

Lam SR, Devenyi RG, Berger AR, Dunn W.

Can J Ophthalmol. 1999 Dec;34(7):389-93.

PMID:
10649580
33.

Prevalence of peripheral neuropathy in injection drug users.

Berger AR, Schaumburg HH, Gourevitch MN, Freeman K, Herskovitz S, Arezzo JC.

Neurology. 1999 Aug 11;53(3):592-7.

PMID:
10449125
34.

Comparison of motor conduction abnormalities in lumbosacral radiculopathy and axonal polyneuropathy.

Berger AR, Sharma K, Lipton RB.

Muscle Nerve. 1999 Aug;22(8):1053-7.

PMID:
10417786
35.

Median mixed and sensory nerve conduction studies in carpal tunnel syndrome.

Scelsa SN, Herskovitz S, Bieri P, Berger AR.

Electroencephalogr Clin Neurophysiol. 1998 Jun;109(3):268-73.

PMID:
9741794
36.

Cytomegalovirus retinitis and low-grade non-Hodgkin's lymphoma: case report and review of the literature.

Derzko-Dzulynsky LA, Berger AR, Berinstein NL.

Am J Hematol. 1998 Mar;57(3):228-32. Review.

37.

Anterior chamber maintenance during drainage of a suprachoroidal hemorrhage in two phakic eyes.

Birt CM, Berger AR.

Ophthalmic Surg Lasers. 1996 Sep;27(9):739-45.

PMID:
8878191
38.

A predominantly motor polyradiculopathy of Lyme disease.

Scelsa SN, Herskovitz S, Berger AR.

Muscle Nerve. 1996 Jun;19(6):780-3. No abstract available.

PMID:
8609932
39.

Myasthenia gravis presenting as uncontrollable flatus and urinary/fecal incontinence.

Berger AR, Swerdlow M, Herskovitz S.

Muscle Nerve. 1996 Jan;19(1):113-4. No abstract available.

PMID:
8538663
40.

The diagnostic utility of F waves in L5/S1 radiculopathy.

Scelsa SN, Herskovitz S, Berger AR.

Muscle Nerve. 1995 Dec;18(12):1496-7. No abstract available.

PMID:
7477082
41.

Long thoracic nerve palsy following cervical chiropractic manipulation.

Oware A, Herskovitz S, Berger AR.

Muscle Nerve. 1995 Nov;18(11):1351. No abstract available.

PMID:
7565940
42.

Low-dose, short-term oral prednisone in the treatment of carpal tunnel syndrome.

Herskovitz S, Berger AR, Lipton RB.

Neurology. 1995 Oct;45(10):1923-5.

PMID:
7477994
43.

The restoration of IVIg efficacy by plasma exchange in CIDP.

Berger AR, Herskovitz S, Scelsa S.

Neurology. 1995 Aug;45(8):1628-9. No abstract available.

PMID:
7644070
44.

Subretinal fibrosis in central serous chorioretinopathy.

Schatz H, McDonald HR, Johnson RN, Chan CK, Irvine AR, Berger AR, Folk JC, Robertson DM.

Ophthalmology. 1995 Jul;102(7):1077-88.

PMID:
9121756
45.

Late motor involvement in cases presenting as "chronic sensory demyelinating polyneuropathy".

Berger AR, Herskovitz S, Kaplan J.

Muscle Nerve. 1995 Apr;18(4):440-4.

PMID:
7715630
46.

Depressor septi nasi myokymia.

Herskovitz S, Bieri PL, Berger AR.

Muscle Nerve. 1994 Jan;17(1):116. No abstract available.

PMID:
8264693
47.

Erythromelalgia: association with hereditary sensory neuropathy and response to amitriptyline.

Herskovitz S, Loh F, Berger AR, Kucherov M.

Neurology. 1993 Mar;43(3 Pt 1):621-2. No abstract available.

PMID:
8451013
48.

2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients.

Berger AR, Arezzo JC, Schaumburg HH, Skowron G, Merigan T, Bozzette S, Richman D, Soo W.

Neurology. 1993 Feb;43(2):358-62.

PMID:
8382349
49.

Dose response, coasting, and differential fiber vulnerability in human toxic neuropathy: a prospective study of pyridoxine neurotoxicity.

Berger AR, Schaumburg HH, Schroeder C, Apfel S, Reynolds R.

Neurology. 1992 Jul;42(7):1367-70.

PMID:
1620347
50.

Brachial plexopathy associated with interleukin-2 therapy.

Loh FL, Herskovitz S, Berger AR, Swerdlow ML.

Neurology. 1992 Feb;42(2):462-3. No abstract available.

PMID:
1310533

Supplemental Content

Loading ...
Support Center